CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction

Nicotine and Tobacco Research

Volumn 16, Issue 9, 2014, Pages

  Chen, Li Shiun ^a   Bach, Richard G ^a   Lenzini, Petra A ^a   Spertus, John A ^b   Bierut, Laura Jean ^a   Cresci, Sharon ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SMOKING CESSATION; ADVERSE EFFECTS; AGED; ALLELE; COMPLICATION; GENETICS; HEART INFARCTION; RISK; RISK FACTOR; SMOKING; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

CHRNA5 PROTEIN, HUMAN; NERVE PROTEIN; NICOTINIC RECEPTOR;

AGED; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NERVE TISSUE PROTEINS; ODDS RATIO; RECEPTORS, NICOTINIC; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 84906047266     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu059     Document Type: Article

References (37)

1. Arnold, S. V., Chan, P. S., Jones, P. G., Decker, C., Buchanan, D. M., Krumholz, H. M., Spertus, J. A. (2011). Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): Design and rationale of a prospective multicenter registry. Circulation: Cardiovascular Quality and Outcomes, 4, 467-476. doi:10.1161/CIRCOUTCOMES.110.960468
2. Baker, T. B., Weiss, R. B., Bolt, D., von Niederhausern, A., Fiore, M. C., Dunn, D. M., Cannon, D. S. (2009). Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine and Tobacco Research, 11, 785-796. doi:10.1093/ ntr/ntp064
3. Bergen, A. W., Javitz, H. S., Krasnow, R., Nishita, D., Michel, M., Conti, D. V., Swan, G. E. (2013). Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenetics and Genomics, 23, 94-103. doi:10.1097/FPC.0b013e32835cdabd
4. Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X., Goate, A. M. (2008). Nicotine dependence and the a5-a3-b4 nicotinic receptor gene cluster: Variants in the nicotinic receptors alter the risk for nicotine dependence. American Journal of Psychiatry, 9, 1163-1171. doi:10.1176/appi.ajp.2008.07111711
5. Bock, B. C., Becker, B. M., Partridge, R., & Niaura, R. (2007). Are emergency chest pain patients ready to quit smoking? Preventive Cardiology, 10, 76-82. doi:10.1111/j.1520-037X.2007.06443.x.
6. Breitling, L. P., Twardella, D., Hoffmann, M. M., Witt, S. H., Treutlein, J., & Brenner, H. (2010). Prospective association of dopamine-related polymorphisms with smoking cessation in general care. Pharmacogenomics, 11, 527-536. doi:10.2217/pgs.10.1
7. CDC. (2007). Cigarettes smoking among adults -United States, 2006. Morbidity and Mortality Weekly Report, 56, 1157-1161.
8. Chen, L. S., Baker, T. B., Grucza, R. A., Johnson, E. O., Breslau, N., Hatsukami, D., Bierut, L. J. (2012). Dissection of the phenotypic and genotypic associations with nicotinic dependence. Nicotine and Tobacco Research, 14, 425-433. doi:10.1093/ntr/ntr231.
9. Chen, L. S., Baker, T. B., Piper, M. E., Breslau, N., Cannon, D. S., Doheny, K. F., Bierut, L. J. (2012). Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. American Journal of Psychiatry, 169, 735-742. doi:10.1176/appi. ajp.2012.11101545
10. Chen, L. S., Johnson, E. O., Breslau, N., Hatsukami, D., Saccone, N. L., Grucza, R. A., Bierut, L. J. (2009). Interplay of distinct genetic risk factors and parent monitoring in risk for nicotine dependence. Addiction, 104, 1731-1740. doi:10.1111/j/1360-0443.2009.02697.x
11. Conti, D. V., Lee, W., Li, D., Liu, J., Van Den Berg, D., Thomas, P. D., Lerman, C. (2008). Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Human Molecular Genetics, 17, 2834-2848. doi:10.1093/hmg/ddn181
12. Cresci, S., Dorn, G. W. 2nd, Jones, P. G., Beitelshees, A. L., Li, A. Y., Lenzini, P. A., Lanfear, D. E. (2012). Adrenergicpathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner. Journal of the American College of Cardiology, 60, 898-907. doi:10.1016/j.jacc.2012.02.051
13. Cresci, S., Wu, J., Province, M. A., Spertus, J. A., Steffes, M., McGill, J. B., Bach, R.G. (2011). Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial. Circulation, 124, 1426-1434. doi:10.1161/CIRCULATIONAHA.111.029173
14. Dawood, N., Vaccarino, V., Reid, K. J., Spertus, J. A., Hamid, N., & Parashar, S. (2008). Predictors of smoking cessation after a myocardial infarction: The role of institutional smoking cessation programs in improving success. Archives of Internal Medicine, 168, 1961-1967. doi:10.1001/ archinte.168.18.1961
15. Drozda, J. Jr., Messer, J. V., Spertus, J., Abramowitz, B., Alexander, K., Beam, C. T., Wong, J. B. (2011). ACCF/ AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Journal of the American College of Cardiology, 58, 316-336. doi:10.1016/j.jacc.2011.05.002
16. Durbin, R. M., Abecasis, G. R., Altshuler, D. L., Auton, A., Brooks, L. D., Gibbs, R. A., McVean, G. A. (2010). A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073. doi:10.1038/nature09534
17. Eisenberg, M. J., Grandi, S. M., Gervais, A., O'Loughlin, J., Paradis, G., Rinfret, S., Pilote, L. (2013). Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: A randomized, placebo-controlled trial. Journal of the American College of Cardiology, 61, 524-532. doi:10.1016/j.jacc.2012.08.1030
18. Fiore, M. C., & Baker, T. B. (2011). Clinical practice. Treating smokers in the health care setting. New England Journal of Medicine, 365, 1222-1231. doi:10.1056/ NEJMcp1101512
19. Freathy, R. M., Ring, S. M., Shields, B., Galobardes, B., Knight, B., Weedon, M. N., Hattersley, A. T. (2009). A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Human Molecular Genetics, 18, 2922-2927. doi:10.1093/hmg/ddp216
20. Greenlund, K. J., Keenan, N. L., Giles, W. H., Zheng, Z. J., Neff, L. J., Croft, J. B., & Mensah, G. A. (2004). Public recognition of major signs and symptoms of heart attack: Seventeen states and the US Virgin Islands, 2001. American Heart Journal, 147, 1010-1016. doi:10.1016/j.ahj.2003.12.036
21. Hospital Quality Alliance (HQA) 2004-2007 measure build out table. (2008). Retrieved January 15, 2008, from www.cms.hhs.gov/HospitalQualityInits/downloads/ HospitalHQA2004_2007200512.pdf
22. Joint Commission on Accreditation of Healthcare Organization (JCAHO). (2007). Acute myocardial infarction: Percent of patients with a history of smoking cigarettes who are given smoking cessation advice or counseling during the hospital stay. Centers for Medicare and Medicaid Services/ The Joint Commission on Accreditation of Healthcare Organizations. (2007). Retrieved January 15, 2008, from http://www.qualitymeasures.ahrq.gov/summary/summary. aspx?ss=2&doc_id=9483.
23. Joseph, A. M., Norman, S. M., Ferry, L. H., Prochazka, A. V., Westman, E. C., Steele, B. G., McGovern, P. G. (1996). The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine, 335, 1792-1798. doi:10.1056/NEJM199612123352402
24. Lanfear, D. E., Jones, P. G., Cresci, S., Tang, F., Rathore, S. S., & Spertus, J. A. (2011). Factors influencing patient willingness to participate in genetic research after a myocardial infarction. Genome Medicine, 3, 39. doi:10.1186/gm255
25. Marsh, S., King, C. R., Garsa, A. A., & McLeod, H. L. (2005). Pyrosequencing of clinically relevant polymorphisms. Methods in Molecular Biology, 311, 97-114. doi:10.1385/1-59259-957-5:097
26. May, F. C., Stocks, N., & Barton, C. (2008). Identification of barriers that impede the implementation of nicotine replacement therapy in the acute cardiac care setting. European Journal of Cardiovascular Prevention & Rehabilitation, 15, 646-650. doi:10.1097/HJR.0b013e3283101075
27. Munafo, M. R., Johnstone, E. C., Walther, D., Uhl, G. R., Murphy, M. F., & Aveyard, P. (2011). CHRNA3 rs1051730 genotype and short-term smoking cessation. Nicotine and Tobacco Research, 13, 982-988. doi:10.1093/ntr/ntr106
28. Piper, M. E., Smith, S. S., Schlam, T. R., Fiore, M. C., Jorenby, D. E., Fraser, D., & Baker, T. B. (2009). A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of General Psychiatry, 66, 1253-1262. doi:10.1001/archgenpsychiatry.2009.142
29. Rea, T. D., Heckbert, S. R., Kaplan, R. C., Smith, N. L., Lemaitre, R. N., & Psaty, B. M. (2002). Smoking status and risk for recurrent coronary events after myocardial infarction. Annals of Internal Medicine, 137, 494-500. doi:10.7326/0003-4819-137-6-200209170-00009.
30. Rigotti, N. A., Clair, C., Munafo, M. R., & Stead, L. F. (2012). Interventions for smoking cessation in hospitalised patients. Cochrane Database System Review, 5:CD001837. doi:10.1002/14651858
31. Saccone, N. L., Culverhouse, R. C., Schwantes-An, T. H., Cannon, D. S., Chen, X., Cichon, S., Bierut, L. J. (2010). Multiple independent loci at chromosome 15q25.1 affect smoking quantity: A meta-analysis and comparison with lung cancer and COPD. PLoS Genetics, 6, 1-16. doi:10.1371/ journal.pgen.1001053
32. Sarginson, J. E., Killen, J. D., Lazzeroni, L. C., Fortmann, S. P., Ryan, H. S., Schatzberg, A. F., Murphy, G. M. (2011). Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156B, 275-284. doi:10.1002/ajmg.b.31155
33. Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification. (2002). Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research, 4, 149-159. doi:10.1080/14622200210123581
34. TAG. (2010). Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nature Genetics, 42, 441-447. doi:10.1038/ng.571
35. Uhl, G. R., Liu, Q. R., Drgon, T., Johnson, C., Walther, D., Rose, J. E., Lerman, C. (2008). Molecular genetics of successful smoking cessation: Convergent genome-wide association study results. Archives of General Psychiatry, 65, 683-693. doi:10.1001/archpsyc.65.6.683
36. Wilson, K., Gibson, N., Willan, A., & Cook, D. (2000). Effect of smoking cessation on mortality after myocardial infarction: Meta-analysis of cohort studies. Archives of Internal Medicine, 160, 939-944. doi:10.1001/ archinte.160.7.939
37. Xian, H., Scherrer, J. F., Madden, P. A., Lyons, M. J., Tsuang, M., True, W. R., & Eisen, S.A. (2003). The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine and Tobacco Research, 5, 245-254. doi:10.1080/14622200307225